Trials / Terminated
TerminatedNCT02657421
OLIF25™ /OLIF51™ Study
A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 168 (actual)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Oblique Lateral Interbody Fusion | The oblique lateral interbody fusion (OLIF) procedures at L2-L5 (OLIF25™) and L5-S1 (OLIF51™) is a minimally invasive surgical option for degenerative lumbar disease. This approach allows for psoas-preserving access to the lumbar spine and minimizes the need to reposition the patient during surgery for accessing additional spinal levels for the interbody fusion portion of the procedure |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-05-03
- Completion
- 2018-05-03
- First posted
- 2016-01-15
- Last updated
- 2018-06-04
Locations
12 sites across 7 countries: United States, Belgium, Czechia, France, Italy, Portugal, Puerto Rico
Source: ClinicalTrials.gov record NCT02657421. Inclusion in this directory is not an endorsement.